Ameriprise’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.85M Buy
452,546
+346,659
+327% +$2.68M ﹤0.01% 2565
2026
Q1
$675K Buy
105,887
+2,595
+3% +$18.1K ﹤0.01% 3462
2025
Q4
$727K Sell
103,292
-40,946
-28% -$247K ﹤0.01% 3480
2025
Q3
$793K Buy
144,238
+66,074
+85% +$324K ﹤0.01% 3461
2025
Q2
$404K Buy
78,164
+58,721
+302% +$352K ﹤0.01% 3599
2025
Q1
$129K Buy
19,443
+7,645
+65% +$58.1K ﹤0.01% 3845
2024
Q4
$87K Buy
+11,798
New +$84.7K ﹤0.01% 3964
2021
Q3
Sell
-18,776
Closed -$525K 3905
2021
Q2
$525K Buy
+18,776
New +$496K ﹤0.01% 3444

Other funds holding LFST

Ameriprise's LFST Position: Q2 2026 in Review

Ameriprise increased its Lifestance Health (LFST) stake by 327% in Q2 2026, buying an estimated $2.68M and bringing the position to 452,546 shares worth $4.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Ameriprise first reported a position in LFST in Q2 2021 and has held it in 8 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Ameriprise held 452,546 shares of Lifestance Health worth $4.85M as of Q2 2026.
  • Ameriprise bought 346,659 Lifestance Health shares in Q2 2026, an estimated $2.68M.
  • Lifestance Health made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2565 holding.
  • Ameriprise first reported a position in Lifestance Health in Q2 2021 and has held it in 8 quarters since.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.